A Genetic Risk Score for the Estimation of Weight Loss After Bariatric Surgery
- PMID: 31898046
- DOI: 10.1007/s11695-019-04320-6
A Genetic Risk Score for the Estimation of Weight Loss After Bariatric Surgery
Abstract
Background: Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most frequent bariatric surgery procedures worldwide. In this prospective study, we examined the association of a genetic risk score (GRS) with loss of excess weight after bariatric surgery.
Methods: A total of forty-seven morbidly obese Greek patients who underwent SG (81%) or RYGB were recruited, followed up for 2 years and genotyped. Weight loss after surgery was reported as the percentage of excess weight that was lost (%EWL) at 12 and 24 months after surgery. A GRS was constructed based on previously BMI- and WHR-related single nucleotide polymorphisms (SNPs) that were found significantly correlated with weight loss after bariatric surgery in our population. The level of post-surgery %EWL after 12 and 24 months was estimated through two multiple linear regression models that considered the effects of relevant genetic risk variants.
Results: The first proposed model suggested that the predictor variables of GRS, age, and BMI had a significant effect on %EWL12m. GRS was significantly associated with %EWL12m, indicating a 4.618% decrease of %EWL12m per score unit. The second model indicated a positive correlation between %EWL24m and %EWL12m, suggesting that while post-surgery weight loss increased during the first 12 months, an increase was expected in the next 12 months as well. GRS was also significantly associated with %EWL24m, indicating approximately 3% decrease of %EWL24m per score unit.
Conclusion: GRS can be used in the future together with other preoperative parameters in order to predict the outcome of bariatric surgery.
Keywords: %EWL; Genetic risk score; Multiple linear regression; One-way ANOVA; Roux-en Y gastric bypass; Sleeve gastrectomy.
Similar articles
-
Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.Surg Obes Relat Dis. 2016 Jun;12(5):997-1002. doi: 10.1016/j.soard.2016.01.020. Epub 2016 Jan 21. Surg Obes Relat Dis. 2016. PMID: 27220823
-
Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.Obes Surg. 2015 Dec;25(12):2251-6. doi: 10.1007/s11695-015-1712-9. Obes Surg. 2015. PMID: 26001882
-
Genetic risk score does not predict the outcome of obesity surgery.Obes Surg. 2014 Jan;24(1):128-33. doi: 10.1007/s11695-013-1080-2. Obes Surg. 2014. PMID: 24065439
-
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6. Int J Surg. 2020. PMID: 32151750
-
Clinical Outcomes of Sleeve Gastrectomy Versus Roux-En-Y Gastric Bypass After Failed Adjustable Gastric Banding.Obes Surg. 2019 Oct;29(10):3252-3263. doi: 10.1007/s11695-019-03988-0. Obes Surg. 2019. PMID: 31292884
Cited by
-
A Clinical-Genetic Score for Predicting Weight Loss after Bariatric Surgery: The OBEGEN Study.J Pers Med. 2021 Oct 17;11(10):1040. doi: 10.3390/jpm11101040. J Pers Med. 2021. PMID: 34683180 Free PMC article.
-
Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity.J Clin Med. 2020 Oct 26;9(11):3430. doi: 10.3390/jcm9113430. J Clin Med. 2020. PMID: 33114543 Free PMC article.
-
Genetic and physiological insights into satiation variability predict responses to obesity treatment.Cell Metab. 2025 Aug 5;37(8):1655-1666.e5. doi: 10.1016/j.cmet.2025.05.008. Epub 2025 Jun 6. Cell Metab. 2025. PMID: 40482646 Clinical Trial.
-
A Systematic Review of Genetic Correlates of Weight Loss After Bariatric Surgery.Obes Surg. 2021 Oct;31(10):4612-4623. doi: 10.1007/s11695-021-05585-6. Epub 2021 Aug 9. Obes Surg. 2021. PMID: 34370160
-
The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.Diabetes Obes Metab. 2024 Apr;26 Suppl 2(Suppl 2):46-63. doi: 10.1111/dom.15555. Epub 2024 Mar 19. Diabetes Obes Metab. 2024. PMID: 38504134 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials